AIG
TBRA

American International Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

American International Group’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,107
Closed -$203K – 3035
2016
Q3 		$203K Buy
5,107
+7
+0.1% +$78 ﹤0.01% 2155
2016
Q2 		$64.1K Buy
5,100
+3,691
+262% +$34.4K ﹤0.01% 2870
2016
Q1 		$12K Hold
1,409
– – ﹤0.01% 4509
2015
Q4 		$14K Sell
1,409
-3
-0.2% -$31 ﹤0.01% 4423
2015
Q3 		$14K Buy
1,412
+1
+0.1% +$14 ﹤0.01% 4407
2015
Q2 		$24.3K Buy
1,411
+332
+31% +$4.85K ﹤0.01% 4320
2015
Q1 		$11.9K Hold
1,079
– – ﹤0.01% 4490
2014
Q4 		$8.87K Sell
1,079
-43
-4% -$370 ﹤0.01% 4565
2014
Q3 		$11.4K Sell
1,122
-1
-0.1% -$20 ﹤0.01% 4482
2014
Q2 		$68.6K Buy
+1,123
New +$68.3K ﹤0.01% 3833

American International Group's TBRA Position: Q4 2016 in Review

American International Group sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 5,107 shares — an estimated $203K sold.

American International Group first reported a position in TBRA in Q2 2014 and held it in 10 quarters. The position peaked at $203K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • American International Group reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • American International Group sold 5,107 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $203K.
  • American International Group first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
  • American International Group's Tobira Therapeutics, Inc. Common Stock position peaked at $203K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on American International Group's 13F filing for Q4 2016, filed 10 Feb 2017.